Exact Mass: 565.2763414
Exact Mass Matches: 565.2763414
Found 140 metabolites which its exact mass value is equals to given mass value 565.2763414
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Coelichelin
A tetrapeptide hydroxamate siderophore that is isolated from Streptomyces coelicolor.
Cinaciguat
Tyr Ile Arg Asp
Val Tyr Arg Glu
Asp Ile Arg Tyr
Asp Ile Tyr Arg
Asp Leu Arg Tyr
Asp Leu Tyr Arg
Asp Arg Ile Tyr
Asp Arg Leu Tyr
Asp Arg Tyr Ile
Asp Arg Tyr Leu
Asp Tyr Ile Arg
Asp Tyr Leu Arg
Asp Tyr Arg Ile
Asp Tyr Arg Leu
Glu Arg Val Tyr
Glu Arg Tyr Val
Glu Val Arg Tyr
Glu Val Tyr Arg
Glu Tyr Arg Val
Glu Tyr Val Arg
Ile Asp Arg Tyr
Ile Asp Tyr Arg
Ile Arg Asp Tyr
Ile Arg Tyr Asp
Ile Tyr Asp Arg
Ile Tyr Arg Asp
Lys Gln Gln Tyr
Lys Gln Tyr Gln
Lys Tyr Gln Gln
Leu Asp Arg Tyr
Leu Asp Tyr Arg
Leu Arg Asp Tyr
Leu Arg Tyr Asp
Leu Tyr Asp Arg
Leu Tyr Arg Asp
Met Pro Arg Tyr
C25H39N7O6S (565.2682394000001)
Met Pro Tyr Arg
C25H39N7O6S (565.2682394000001)
Met Arg Pro Tyr
C25H39N7O6S (565.2682394000001)
Met Arg Tyr Pro
C25H39N7O6S (565.2682394000001)
Met Tyr Pro Arg
C25H39N7O6S (565.2682394000001)
Met Tyr Arg Pro
C25H39N7O6S (565.2682394000001)
Pro Met Arg Tyr
C25H39N7O6S (565.2682394000001)
Pro Met Tyr Arg
C25H39N7O6S (565.2682394000001)
Pro Arg Met Tyr
C25H39N7O6S (565.2682394000001)
Pro Arg Tyr Met
C25H39N7O6S (565.2682394000001)
Pro Tyr Met Arg
C25H39N7O6S (565.2682394000001)
Pro Tyr Arg Met
C25H39N7O6S (565.2682394000001)
Gln Lys Gln Tyr
Gln Lys Tyr Gln
Gln Gln Lys Tyr
Gln Gln Tyr Lys
Gln Tyr Lys Gln
Gln Tyr Gln Lys
Arg Asp Ile Tyr
Arg Asp Leu Tyr
Arg Asp Tyr Ile
Arg Asp Tyr Leu
Arg Glu Val Tyr
Arg Glu Tyr Val
Arg Ile Asp Tyr
Arg Ile Tyr Asp
Arg Leu Asp Tyr
Arg Leu Tyr Asp
Arg Met Pro Tyr
C25H39N7O6S (565.2682394000001)
Arg Met Tyr Pro
C25H39N7O6S (565.2682394000001)
Arg Pro Met Tyr
C25H39N7O6S (565.2682394000001)
Arg Pro Tyr Met
C25H39N7O6S (565.2682394000001)
Arg Val Glu Tyr
Arg Val Tyr Glu
Arg Tyr Asp Ile
Arg Tyr Asp Leu
Arg Tyr Glu Val
Arg Tyr Ile Asp
Arg Tyr Leu Asp
Arg Tyr Met Pro
C25H39N7O6S (565.2682394000001)
Arg Tyr Pro Met
C25H39N7O6S (565.2682394000001)
Arg Tyr Val Glu
Val Glu Arg Tyr
Val Glu Tyr Arg
Val Arg Glu Tyr
Val Arg Tyr Glu
Val Tyr Glu Arg
Tyr Asp Ile Arg
Tyr Asp Leu Arg
Tyr Asp Arg Ile
Tyr Asp Arg Leu
Tyr Glu Arg Val
Tyr Glu Val Arg
Tyr Ile Asp Arg
Tyr Lys Gln Gln
Tyr Leu Asp Arg
Tyr Leu Arg Asp
Tyr Met Pro Arg
C25H39N7O6S (565.2682394000001)
Tyr Met Arg Pro
C25H39N7O6S (565.2682394000001)
Tyr Pro Met Arg
C25H39N7O6S (565.2682394000001)
Tyr Pro Arg Met
C25H39N7O6S (565.2682394000001)
Tyr Gln Lys Gln
Tyr Gln Gln Lys
Tyr Arg Asp Ile
Tyr Arg Asp Leu
Tyr Arg Glu Val
Tyr Arg Ile Asp
Tyr Arg Leu Asp
Tyr Arg Met Pro
C25H39N7O6S (565.2682394000001)
Tyr Arg Pro Met
C25H39N7O6S (565.2682394000001)
Tyr Arg Val Glu
Tyr Val Glu Arg
Tyr Val Arg Glu
Fibrinogen-Binding Peptide
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin[1].
4,4,4-trifluoro-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
JNJ-31020028
JNJ-31020028 is a selective and brain penetrant antagonist of neuropeptide Y Y2 receptor with pIC50 values of 8.07 and 8.22 for human and rat Y2 receptor, respectively. JNJ-31020028 can be used for the research of nervous disease[1].